Ridloff Elena
CFO and CBO
Ridloff Elena has filed 4 SEC Form 4 filings (11 transaction rows) across 2 companies, including SION, KYMR, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Ridloff Elena is listed as Director at Kymera Therapeutics, Inc. Inside the rolling window, Ridloff Elena reported no open-market purchases and 3 open-market sales totaling $1.3M in KYMR. The largest disclosed transaction in the window is a sale of 7,400 KYMR shares on Mar 31, 2026, worth $632K.
Companies traded
Other insiders at SION
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Ridloff Elena made?
Ridloff Elena has filed 4 SEC Form 4 filings (11 transaction rows) across 2 companies, including SION, KYMR since 2025.
Which companies does Ridloff Elena trade?
Ridloff Elena has filed SEC Form 4 disclosures for 2 companies, including SION, KYMR.
When was Ridloff Elena's most recent SEC Form 4 filing?
Ridloff Elena's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Ridloff Elena's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ridloff Elena is listed as CFO and CBO.
What is Ridloff Elena's total buy and sell value in the current window?
Inside the rolling retention window, Ridloff Elena bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Ridloff Elena's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,400 KYMR shares on 2026-03-31, worth $632K, per SEC Form 4 filings.